Make sure not to miss this valuable item your first time around. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Add us as a preferred source on ...
Launched in 2019, the Syn-One Test is used by neurologists and other clinicians in all 50 states to aid in the diagnosis of synucleinopathies SCOTTSDALE, Ariz., Nov. 6, 2025 /PRNewswire/ -- CND Life ...
Christians have “much to offer” a world where the nuclear threat persists in an era of increasing division and complexty, the annual meeting of Christian CND was told. Delegates switched late in the ...
CND Life Sciences Inc, a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated biomarker services, announced that the US Food and Drug Administration ...
SCOTTSDALE, Ariz., Oct. 7, 2025 /PRNewswire/ -- CND Life Sciences, Inc. (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated biomarker ...
The company was sentenced in Shepparton Magistrates’ Court on Wednesday for failing to provide and maintain a safe system of work, and failing to provide workers with necessary supervision. The ...
Campaigners have called for government "transparency" amid reports the United States Air Force has moved nuclear weapons to a Suffolk airbase. Flight data showed a specialist C-17A Globemaster ...
Several organizations signed a joint statement on Wednesday, calling for the United Nations Office on Drugs and Crime (UNODC) and the Commission on Narcotic Drugs (CND) to take action put an end to ...
Us Weekly has affiliate partnerships. We receive compensation when you click on a link and make a purchase. Learn more! If you’re deep in the nail girlie lifestyle, chances are those stunning manis ...
SCOTTSDALE, Ariz., May 1, 2025 /PRNewswire/ -- CND Life Sciences, Inc. (CND) announced today that it has raised $13.5 million in its Series A equity financing round, with $8.6 million in its most ...
(MENAFN- PR Newswire) "This is a defining time for the neurodegeneration field," said Richard J. Morello, CND's chief executive officer. "CND uses proven technology to help clinicians diagnose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback